Biotest AG
BTTAYOTCHealthcare
$24.23
+$0.00(+0.00%)
Market Cap$943029783
P/E Ratio—
52W High$24.27
52W Low$22.8
Biotest AG (BTTAY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BTTAY · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2025Report Date: May 12, 2025EPS Actual
-$0.55
Revenue
$0.12B
Fiscal Period
Q2 FY2025
FY ends December
Report Date
May 12, 2025
After Market Close
BTTAY reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2025 | Nov 10, 2025 | — | — | — | — | — | — |
| ◌ Q3 FY2025 | Aug 4, 2025 | — | — | — | — | — | — |
| — Q2 FY2025 | May 12, 2025 | — | -$0.55 | — | $0.12B | — | — |
| — Q1 FY2025 | Mar 31, 2025 | — | -$0.09 | — | $0.20B | — | — |
| — Q4 FY2024 | Nov 14, 2024 | — | -$0.25 | — | $0.15B | — | — |
| — Q3 FY2024 | Jul 30, 2024 | — | $0.25 | — | $0.16B | — | — |
| — Q2 FY2024 | May 7, 2024 | — | $0.74 | — | $0.22B | — | — |
| — Q1 FY2024 | Mar 28, 2024 | — | $0.97 | — | $0.18B | — | — |
Q4 FY2025
Nov 10, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 4, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 12, 2025
EPS Actual
-$0.55
EPS Est.
—
EPS Surpr.
—
Revenue
$0.12B
Q1 FY2025
Mar 31, 2025
EPS Actual
-$0.09
EPS Est.
—
EPS Surpr.
—
Revenue
$0.20B
Q4 FY2024
Nov 14, 2024
EPS Actual
-$0.25
EPS Est.
—
EPS Surpr.
—
Revenue
$0.15B
Q3 FY2024
Jul 30, 2024
EPS Actual
$0.25
EPS Est.
—
EPS Surpr.
—
Revenue
$0.16B
Q2 FY2024
May 7, 2024
EPS Actual
$0.74
EPS Est.
—
EPS Surpr.
—
Revenue
$0.22B
Q1 FY2024
Mar 28, 2024
EPS Actual
$0.97
EPS Est.
—
EPS Surpr.
—
Revenue
$0.18B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2025 | May 12, 2025 | — | $24.23 | $24.23 | +0.00% |
| — Q1 FY2025 | Mar 31, 2025 | — | $24.27 | $22.80 | -6.06% |
| — Q4 FY2024 | Nov 14, 2024 | — | No price data | $24.27 | — |
| — Q3 FY2024 | Jul 30, 2024 | — | No price data | $24.27 | — |
| — Q2 FY2024 | May 7, 2024 | — | No price data | $24.27 | — |
| — Q1 FY2024 | Mar 28, 2024 | — | No price data | $24.27 | — |
| — Q3 FY2023 | Sep 30, 2023 | — | No price data | $24.27 | — |
| — Q2 FY2023 | Jun 30, 2023 | — | No price data | $24.27 | — |
Q2 FY2025+0.00%
Report Date
May 12, 2025
EPS Beat/Miss
—
Price Before
$24.23
Price After
$24.23
Q1 FY2025-6.06%
Report Date
Mar 31, 2025
EPS Beat/Miss
—
Price Before
$24.27
Price After
$22.80
Q4 FY2024—
Report Date
Nov 14, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$24.27
Q3 FY2024—
Report Date
Jul 30, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$24.27
Q2 FY2024—
Report Date
May 7, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$24.27
Q1 FY2024—
Report Date
Mar 28, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$24.27
Q3 FY2023—
Report Date
Sep 30, 2023
EPS Beat/Miss
—
Price Before
—
Price After
$24.27
Q2 FY2023—
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
—
Price After
$24.27
Beat Rate0 / 8 quarters
Largest Move-6.06% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BTTAY ends December
Biotest AG (BTTAY) most recently reported earnings on May 12, 2025 for Q2 FY2025, posting EPS of $-0.55 (in line with the analyst consensus of —). The next BTTAY earnings date is expected around September 1, 2026.
Each quarter, investors track BTTAY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BTTAY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BTTAY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BTTAY earnings · 4 questionsBiotest AG's next earnings report is expected around September 1, 2026. BTTAY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BTTAY historically reports after market close (AMC).
BTTAY earnings datewhen is BTTAY earningsBTTAY next earnings datewhen does BTTAY report earningsBTTAY earnings calendar
▸ Source: FMP · Biotest AG SEC filings · US GAAP · Biotest AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026